ArticleBMC biology2025
Integration of pre-trained protein language models with equivariant graph neural networks for peptide toxicity prediction.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- ToxiCompass: an evidence-tracked benchmark for short-peptide toxicity screening and confidence-aware assay prioritization.Briefings in bioinformatics · 2026Article
- Review
- CLABP: a contrastive learning framework integrating protein language models and structural information for antibacterial peptide prediction.Briefings in bioinformatics · 2026Article
- Predicting protein-protein interaction sites based on dynamic perception mechanism within a hierarchical E(n)-equivariant graph.Briefings in bioinformatics · 2026Article
- AFP-GFuse: an antifungal peptide identification model with structural information fusion via multi-graph neural networks and cross-attention mechanism.Molecular diversity · 2026Article
- Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance.Antibiotics (Basel, Switzerland) · 2026Review
- IntelligentFrontiers in cellular and infection microbiology · 2026Article
- TruMPET: A New Method for Protein Secondary Structure Prediction Using Neural Networks Trained on Multiple Pre-Selected Physicochemical and Structural Features.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPeptide-based therapeutics have great potential due to their versatility, high specificity, and suitability for a variety of therapeutic applications. Despite these advantages, the inherent toxicities of some peptides pose challenges in drug development. Several computational methods have been developed to allow rapid and efficient large-scale screening of peptide toxicity. However, these methods mainly rely on the primary sequence and often ignore critical structural information, which limits their predictive accuracy.
resultsIn this study, we introduce a novel framework named StrucToxNet that integrates a pre-trained protein language model with an equivariant graph neural network to improve peptide toxicity prediction. By combining sequence embeddings from the ProtT5 language model and 3D structural data predicted by ESMFold, StrucToxNet can capture both sequential and spatial characteristics of peptides. Testing on the independent dataset indicates that StrucToxNet outperforms existing sequence-based models in various metrics, achieving higher balanced accuracy and overall performance.
conclusionsThe results demonstrate the robustness and generalizability of StrucToxNet, marking it a reliable tool in the computational screening of toxic peptides and facilitating safer peptide-based drug development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.